Also, we demonstrated that treatment of toxoplasma-infected animals with surrogate marker-specific non-exhausted CD4 population reversed CD8 exhaustion and controlled the reactivation of latent infection (17). This evidence concerns the gene CD4 and disease arising from reactivation of latent virus.